Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 1,060,902 | 1,189,248 | 1,047,265 | 1,006,083 | 918,499 |
| Cost of Goods | 187,503 | 200,710 | 179,404 | 180,190 | 159,682 |
| Gross Profit | 873,399 | 988,538 | 867,861 | 825,893 | 758,817 |
| Operating Expenses | 727,712 | 800,895 | 735,761 | 687,461 | 617,837 |
| Operating Income | 146,190 | 188,353 | 132,504 | 138,622 | 141,662 |
| Interest Expense | 66 | 36 | 46 | 444 | 15 |
| Other Income | 4,372 | 3,193 | 2,182 | 374 | 942 |
| Pre-tax Income | 150,496 | 191,510 | 134,640 | 138,552 | 142,589 |
| Income Tax | 49,970 | 65,286 | 72,105 | 38,511 | 47,917 |
| Net Income Continuous | 100,526 | 126,224 | 62,535 | 100,041 | 94,672 |
| Net Income | $100,526 | $126,224 | $62,535 | $100,041 | $94,672 |
| EPS Basic Total Ops | 4.44 | 5.24 | 2.57 | 4.14 | 3.72 |
| EPS Basic Continuous Ops | 4.44 | 5.24 | 2.57 | 4.14 | 3.72 |
| EPS Diluted Total Ops | 4.41 | 5.12 | 2.53 | 3.99 | 3.59 |
| EPS Diluted Continuous Ops | 4.41 | 5.12 | 2.53 | 3.99 | 3.59 |
| EPS Diluted Before Non-Recurring Items | 4.41 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $169,197 | $205,196 | $148,614 | $152,104 | $151,640 |